LYEL:NASDAQ
Lyell Immunopharma Inc
$8.12
arrow_downward
-0.85%(-0.070) 1D
$8.12
0.00% (0.00)
bedtimePagkalipas ng oras ng trabaho
Sarado: Okt 16, 4:00:01 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa LYEL...
Buksan
$8.24
Mataas
$8.44
Mababa
$7.92
Mkt. cap
198.98M
Avg. na dami
158.44K
Dami
194.96K
Mataas nang 52-wk
$45.00
Mababa nang 52-wk
$7.32
EPS
-$12.01
Beta
-0.03
Mga natitirang share
24.50M
Bilang ng mga empleyado
161
Buksan
$8.24
Mataas
$8.44
Mababa
$7.92
Mkt. cap
198.98M
Avg. na dami
158.44K
Dami
194.96K
Mataas nang 52-wk
$45.00
Mababa nang 52-wk
$7.32
EPS
-$12.01
Beta
-0.03
Mga natitirang share
24.50M
Bilang ng mga empleyado
161
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
investingLive
·
15 oras ang nakalipas
S&P 500 analysis and forecast after the "AI bubble" panic
Bloomberg.com
·
1 araw ang nakalipas
S&P 500 Steady as Warsh Boosts Expectations of Rate Hold
MarketWatch
·
1 buwan ang nakalipas
The S&P 500 keeps climbing on days when stocks broadly struggle. Here’s what’s going on.
24/7 Wall St.
·
5 araw ang nakalipas
You Bought VOO to Own the S&P 500. On $500,000, One Chipmaker Is $40,400 of It
Profile
Lyell Immunopharma, Inc. is an American clinical-stage biopharmaceutical company headquartered in San Francisco, California. Founded in 2018, the company develops next-generation cell therapies, including CAR T cell, using technologies intended to improve T-cell persistence, function, and resistance to exhaustion. Its pipeline includes therapies being developed for hematologic malignancies and solid tumors. Wikipedia
Tungkol sa Lyell Immunopharma Inc
CEO-
Mga Empleyado161
Itinatag2018
HeadquartersSouth San Francisco, California, Estados Unidos
Sektor-
Websitelyell.com